Advertisement

Topics

AnGes MG, Inc. Company Profile

14:03 EST 13th December 2018 | BioPortfolio

Capitalization : 5,503million yen(at the end of December 2005) Issued and outstanding : 101,503shares (at the end of December 2005)
Number of employees : 89 (to be consolidated at the end of December 2005)
Scope of business :
1. Research, development and manufacturing of HGF genetic medication
2. Research, development and manufacturing of nucleatic acid drugs (NFB decoy oligo nucleotides)
3. Research and development of new vectors (HVJ envelope vector) to form the company's business platform

Location

4F, Saito Bio-Incubator, 7-7-15, Saito-asagi,
Ibaraki
Osaka
567-0085
Japan

Contact

Email: info@anges-mg.com


News Articles [7 Associated News Articles listed on BioPortfolio]

Vasomune, AnGes Sign Global Agreement

For the development & commercialization of treatments for diseases tied to with blood vessel dysfunction & destabilization

Inversago brings in $7mm via Series A

Inversago Pharma Inc. raised $7mm through its Series A financing co-led by Genesys Capital and AmorChem, which were joined by JDRF T1D Fund, Accel-Rx, Anges Québec Capital, Tarnagulla Ventures, and a...

AnGes Inc 4563 Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryAnGes Inc AnGes is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specia...

AnGes Inc 4563 Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250

SummaryAnGes Inc AnGes is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specia...

AnGes Inc 4563 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryAnGes Inc AnGes is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specia...

AnGes Inc 4563 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryAnGes Inc AnGes is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specia...

AnGes Inc 4563 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAnGes Inc AnGes is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specia...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

AnGes MG, Inc.

Capitalization : 5,503million yen(at the end of December 2005) Issued and outstanding : 101,503shares (at the end of December 2005) Number of employees : 89 (to be consolidated at the end of December ...

More Information about "AnGes MG, Inc." on BioPortfolio

We have published hundreds of AnGes MG, Inc. news stories on BioPortfolio along with dozens of AnGes MG, Inc. Clinical Trials and PubMed Articles about AnGes MG, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AnGes MG, Inc. Companies in our database. You can also find out about relevant AnGes MG, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record